Liver vaccine of fifth of our country finishes three clinical trials

Liver vaccine of fifth of our country finishes three clinical trials
Liver vaccine of fifth of our country finishes three clinical trials
It is reported ' Reporter Wang Dan) Hree clinical trials reagent and the intersection of vaccine and the intersection of engineering and the intersection of research center and fifth type vaccine of hepatitis developed to take the lead in finish three clinical trials a few days ago, fifth type vaccine of hepatitis studied before becoming the world firstly to all finish clinically. August 23, the international authoritative magazine " lancet " has issued this result of study, the hepatitis chief of the office Dr. Mu Burger Huo of Center for Disease Prevention and Control of U.S.A. has spoken highly of this result. It is introduced, the fifth type hepatitis vaccine clinical trial of our country lasts 5 years, recruit over 110,000 volunteers, it is three clinical research of global largest vaccine up until now. In this test, are tried vaccine and demonstrated 100% of the protection rate to each age group in the test, the bad reaction lacks and very slight, has not presented the relevant serious bad incident of vaccine, it is safe, effective to show vaccine. It is reported, fifth type hepatitis is one of the main virus hepatitis, there is not vaccine yet both at home and abroad. About 1/3 of the people in the world have been infected with the liver virus of fifth. Our country is the fifth type high prevailing area of hepatitis, in 1986 - 1988, fifth type hepatitis happens to break out prevailingly in Xinjiang Uygur Autonomous Regions of our country, 119280 of onset, 707 of death, most big fifth type hepatitis break out, prevail incident in the world up until now. Regarded as biological medicine of originality with the totally independent intellectual property right of our country, already there are 5 patents for invention at home and abroad by the fifth type vaccine of hepatitis trying this time. At present, this vaccine has already entered national food medicines to supervise the administration bureau examining and commenting the procedure specially, once can be used clinically through examination and approval. Relevant experts emphasize while giving an interview, though fifth type vaccine of hepatitis has already been developed successfully, but suitable inoculation crowd, inoculating the dosage and inoculating the method,etc. prevents the tactics at present specifically not clear yet, in should also need to study more spend, while being large-scale while being clinical.


|